Abstract
Quercetin and 12 other natural flavonoid aglycones inhibit washed human platelet aggregation and secretion of serotonin induced by ADP, collagen or thrombin. The inhibitory effect of flavonoids is of the same order of magnitude as IBMX and dipyridamole.
The structural features required for a flavonoid to inhibit human platelet function are similar to those previously reported by us to inhibit cyclic nucleotide phosphodiesterase. The inhibitory effect of flavonoids on human platelet function was diminished by saturation of the C-2, C-3 double bond, lack of the C-4 carbonyl, glycosylation at C-3 and a high number of hydroxyl substituents.
Similar content being viewed by others
References
J.F. Mustard,Function of blood platelets and their role in thrombosis, Trans. Am. Clin. Climatol. Ass.87, 104–127 (1976).
R. Ross andJ.A. Glomset,The pathogenesis of atherosclerosis, N. Eng. J. Med.295, 369–377; 420–425 (1976).
S.U. Bjorkerud,Mechanisms of atherosclerosis, Pathobiol. Annu.9, 277 (1979).
M.A. Packham andJ.F. Mustard,Clinical pharmacology of platelets, Blood50, 555–573 (1977).
A. Beretz, R. Anton andJ.C. Stoclet,Flavonoid compounds are potent inhibitors of cyclic AMP phosphodiesterase, Experientia34, 1054–1055 (1978).
J.E. Perrell, P.G.D. Chang Sing, G. Loew, R. King, J.M. Mansour andT.E. Mansour,Structure-activity studies of flavonoids as inhibitors of cyclic AMP phosphodiesterase and relationship to quantum chemical indices, Mol. Pharmac.16, 556–568 (1979).
M. Ruckstuhl, A. Beretz, R. Anton andY. Landry,Flavonoids are selective cyclic GMP phosphodiesterase inhibitors, Biochem. Pharmac.28, 535–538 (1979).
M. Ruckstuhl andY. Landry,Inhibition of lung cyclic AMP- and cyclic GMP-phosphodiesterases by flavonoids and other chromone-like compounds, Biochem. Pharmac.30, 697–702 (1981).
T. Pollock andH. Heath,Studies on the effects of ββ′-iminodipropionitrile and O-(β-hydroxyethyl)-rutoside on ADP-activated aggregation of rat platelets in relation to the development of diabetic microangiopathy, Biochem. Pharmac.24, 397–400 (1975).
J.W. Ten Cate, N.J. Van Haeringen, J., Gerritsen andE. Glasius,Biological activity of a semisynthetic flavonoid, O-(β-hydroxyethyl) rutoside: light-scattering and metabolic studies of human red cells and platelets, Clin. Chem.19, 31–35 (1973).
E. Sempinska, B. Kostka, M., Krolikowska andE. Kalisiak,Effect of flavonoids on the platelet adhesiveness in repeatedly bred rats, Pol. J. Pharmac. Pharm.29, 7–10 (1977).
J. Hladovec,Antithrombotic effects of some flavonoids alone and combined with acetylsalicylic acid, Arzneim. Forsch.27, 1989–1992 (1977).
J.-P. Cazenave, M.A. Packham andJ.F. Mustard,Adherence of platelets to a collagen-coated surface: a development of a quantitative method, J. Lab. Clin. Med.82, 978–990 (1973).
J.F. Mustard, D.W. Perry, R.L. Kinlough-Rathbone andM.A. Packham,Factors responsible for ADP-induced release reaction of human platelets, Am. J. Physiol.228, 1757–1765 (1975).
R.L. Kinlough-Rathbone, J.F. Mustard, M.A. Packham, D.W. Perry, H.-J. Reimers andJ.-P. Cazenave,Properties of washed human platelets, Thromb. Haemostasis37, 291–308 (1977).
R.H. Aster andJ.H. Jandl,Platelet sequestration in man. I. Methods, J. Clin. Invest.43, 843–855 (1964).
J. Molnar andL. Lorand,Studies on apyrases, Arch. Biochem. Biophys.93, 353–363 (1961).
J.-P. Cazenave, H.-J. Reimers, R.L. Kinlough-Rathbone, M.A. Packham andJ.F. Mustard,Effects of sodium periodate on platelet functions, Lab. Invest.34, 471–481 (1976).
N.G. Ardlie, G. Glew, B.G. Schultz andC.J. Schwartz,Inhibition and reversal of platelet aggregation by methylxanthines, Thromb. Diath. Haemorrh.18, 670–673 (1967).
S.S. Tang andM.M. Frojmovic,Inhibition of platelet function by antithrombotic agents which selectively inhibit low-Km cyclic 3′,5′-adenosine monophosphate phosphodiesterase, J. Lab. Clin. Med.95, 241–257 (1980).
H. Hidaka, H. Hayashi, H. Kohri, H. Kimura, T. Hosokawa, T. Igawa andY. Saitoh,Selective inhibitor of platelet cyclic adenosine monophosphate phosphodiesterase, cilostamide, inhibits platelet aggregation, J. Pharmac. Exp. Ther.211, 26–30 (1979).
J.-P. Cazenave, A. Beretz, A. Stierle andR. Anton,Role of cyclic AMP in the inhibition of human platelet functions by quercetin, a flavonoid that potentiates PGI 2 effect, Thromb. Haem.46, 173 (1981).
R.C. Robbins,Stabilization of flow properties of blood with phenylbenzo-γ-pyrone derivatives (flavonoids), Int. J. Vit. Nutr. Res.47, 373–382 (1977).
B. Sarkadi, I. Szasz andG. Gardos,Characteristics and regulation of active calcium transport in inside-out red cell membrane vesicles, Biochim. Biophys. Acta98, 326–338 (1980).
A. Wuthrich andH.J. Schatzman,Inhibition of the red cell calcium pump by quercetin, Cell Calcium1, 21–35 (1980).
C.M.S. Fewtrell andB.D. Gomperts,Quercetin: a novel inhibitor of Ca 2+-influx and exocytosis in rat peritoneal mast cells, Biochim. Biophys. Acta469, 52–60 (1977).
J.P. Bennett, B.D. Gomperts andE. Wollenweber,Inhibitory effects of natural flavonoids on secretion from mast cells and neutrophils, Arzneim.-Forsch.31, 433–437 (1981).
V. Shoshan, K.P. Campbell, D.H. MacLennan, W. Frodis andB.A. Britt,Quercetin inhibits Ca 2+ uptake but not Ca 2+ release by sarcoplasmic reticulum in skinned muscle fibers, Proc. Natn. Acad. Sci. USA77, 4435–4438 (1980).
G.D. Long, L.R. Dechatelet, J.T. O'Flaherty, C.E. McCall, D.A. Bass, P.S. Shirley andJ.W. Parce,Effects of quercetin on magnesium-dependent adenosine triphosphatase and the metabolism of human polymorphonuclear leukocytes, Blood57, 561–566 (1981).
G.A. Kimmich andJ. Randles,Phloretin-like action of bioflavonoids on sugar accumulation capability of isolated intestinal cells, Membr. Biochem.1, 221–237 (1978).
J. Baumann, F. v. Bruchausen andG. Wurm,Structure-activity study on the influence of phenolic compounds and bioflavonoids on rat renal prostaglandin synthetase, Naunyn-Schmiedeberg's Arch. Pharmak.307, 73–78 (1979).
J. Baumann, G. Wurm andF. v. Bruchausen,Hemmung der Prostaglandinsynthetase durch Flavonoide und Phenolderivate im Vergleich mit deren O − 2 Radikalfängereigenschaften, Arch. Pharmazie313, 330–337 (1980).
R.L. Kinlough-Rathbone, M.A. Packham, H.-J. Reimers, J.-P. Cazenave andJ.F. Mustard,Mechanisms of platelet shape change, aggregation and release induced by collagen, thrombin or A 23187, J. Lab. Clin. Med.90, 707–719 (1977).
L. Cavallini, A. Bindoli andN. Siliprandi,Comparative evaluation of antiperoxidative action of silymarin and other flavonoids, Pharmac. Res. Commun.10, 133–136 (1978).
M. Greenberg, R.W. Grady andC.M. Peterson,Inhibition of platelet function with 2,3-dihydroxybenzoic acid, Br. J. Haematol.37, 569–577 (1977).
V.S. Kamat, F.Y. Chuo, I. Kubo andK. Nakanishi,Antimicrobial agents from an east African medicinal plant, Erythrina abyssinica, Heterocycles15, 1163–1170 (1981).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Beretz, A., Cazenave, JP. & Anton, R. Inhibition of aggregation and secretion of human platelets by quercetin and other flavonoids: Structure-activity relationships. Agents and Actions 12, 382–387 (1982). https://doi.org/10.1007/BF01965408
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF01965408